ACXP גידול ברווח למניה בשנה הנוכחית Acurx Pharmaceuticals
The annual net income per share history on the current GURU.Markets platform chart shows that 67.20 represents the latest metric reading. Acurx Pharmaceuticals (ACXP) is implementing eco-friendly waste disposal methods in compliance with ESG standards. The brand is valued for its innovative antibiotics targeting resistant microbes. Experienced management is effectively optimizing clinical trial strategies to minimize potential risks.
פילוחים אנליטיים ודוחות נתונים של חברת acurxpharma.com (ACXP)
Acurx Pharmaceuticals' development of selective antibiotics against superbugs requires colossal investments that impact net income. This metric is calculated as the ratio of current earnings per share to the same figure from the previous year, quantifying the capitalization efficiency of R&D processes. The trend in the percentage change of earnings per share compared to last year allows for the filtering of market noise, revealing the company's real fundamental progress.
